Abstract

Value-Based Insurance Design (VBID) is intended to incentivize the use of services that are most cost-effective for patient care. One strategy is to reduce patient cost-sharing of medications that are crucial for chronic disease, such as inhalers for asthma and/or chronic obstructive pulmonary disease (COPD). Recently, several benefit changes have been introduced into an employee health plan for a large health system in Texas, including co-pay reductions, deductible elimination, and income-based premium subsidies. This study evaluated the impact of these interventions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call